晶苑(02232.HK)逆涨15%越50天线 为港府生产重用口罩
晶苑国际(02232.HK)为港府生产可重用 「铜芯抗疫口罩」,该股今早一举升破10天、20天及50天线(2.2元),最高见2.32元,半日收2.3元,急涨15%,一向薄弱的成交半日急增至493万股,涉资1,102万元。
创新及科技局常任秘书长蔡淑娴於电台证实,晶苑国际位於越南的生产线为港府生产可重用 「铜芯抗疫口罩」。蔡淑娴解释当初不公开生产商名称,是不想麻烦对方,昨日徵求同意後决定公开生产商身份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.